Use of Recombinant Activated Factor VII in Bleeding Lung Transplant Patients Undergoing Perioperative ECMO Therapy †

Background: Hemostasis in critically ill patients represents a fragile balance between hypocoagulation and hypercoagulation, and is influenced by various factors. Perioperative use of extracorporeal membrane oxygenation (ECMO)—increasingly used in lung transplantation—further destabilizes this balan...

Descripción completa

Detalles Bibliográficos
Autores principales: Laxar, Daniel, Schaden, Eva, Wiegele, Marion, Hötzenecker, Konrad, Schwarz, Stefan, Gratz, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140848/
https://www.ncbi.nlm.nih.gov/pubmed/37109356
http://dx.doi.org/10.3390/jcm12083020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140848/
https://www.ncbi.nlm.nih.gov/pubmed/37109356
http://dx.doi.org/10.3390/jcm12083020

Ejemplares similares